IgG1 anti-EGFR antibody binds EGFR on target cells and engages Fcγ receptors on effector cells to trigger ADCC (and potentially CDC), leading to immune-mediated killing of EGFR-expressing cells; it also blocks EGFR signaling (growth inhibition).